INVASIVE LOBULAR CARCINOMA
Clinical trials for INVASIVE LOBULAR CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new INVASIVE LOBULAR CARCINOMA trials appear
Sign up with your email to follow new studies for INVASIVE LOBULAR CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can Pre-Surgery hormone therapy help lobular breast cancer patients?
Disease control Recruiting nowThis study looks at whether giving hormone therapy before breast-conserving surgery helps reduce leftover cancer cells at the edges of removed tissue. It involves 176 postmenopausal women with stage 2-3 ER+/HER2- invasive lobular carcinoma. The goal is to see if this approach lea…
Matched conditions: INVASIVE LOBULAR CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New short radiation regimen aims to cut side effects in breast cancer treatment
Disease control Recruiting nowThis study is testing whether a shorter, higher-dose radiation treatment (APBI) given over just three days is safe and effective for women with early-stage breast cancer or DCIS who have had a lumpectomy. The goal is to see if this approach causes fewer or milder side effects com…
Matched conditions: INVASIVE LOBULAR CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 17:32 UTC
-
New PET scan aims to spot hidden cancer spread
Diagnosis Recruiting nowThis early-phase study is testing whether a special PET scan using a drug called PYLARIFY can better detect cancer that has spread in people with pancreatic cancer, liver cancer, or breast cancer. About 36 adults will receive the scan, and doctors will compare the results to stan…
Matched conditions: INVASIVE LOBULAR CARCINOMA
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
Can mapping tumor DNA unlock personalized breast cancer care?
Knowledge-focused Recruiting nowThe AURORA study is collecting tumor and blood samples from 1,300 people with metastatic breast cancer across Europe. By analyzing genetic changes in both the original and metastatic tumors, researchers hope to understand why some patients respond well to therapy while others do …
Matched conditions: INVASIVE LOBULAR CARCINOMA
Phase: NA • Sponsor: Jules Bordet Institute • Aim: Knowledge-focused
Last updated Aug 08, 2026 00:03 UTC